1st Quarter - Report

TIBER CREEK HEALTH STRATEGIES, INC. for GENENTECH, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the Public Health Service Act-340b pricing, S. 469 Affordable and Safe Prescription Drug Importation Act

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE

Bills named: S. 469 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.